IGF1 and breast cancer: Using MCF-7 breast cancer cells and ECC-1 endometrial cells, Nahum et al. [61] found that lycopene and all-trans retinoic acid (ATRA) inhibited IGF-1 stimulated cell-cycle progression through the G1 and S phases and also inhibited Rb phosphorylation.